MOUNTAIN VIEW, Calif., March 21 /PRNewswire-FirstCall/ -- Pharsight Corporation , a leading provider of software and strategic services for optimizing clinical drug development, announced today that Andreas Krause, Ph.D., Senior Scientist, will speak to members of the European pharmaceutical industry attending the Insightful Life Sciences Event on Clinical Data Review and Reporting, to be held at the Hotel Victoria in Basel, Switzerland, on March 24, 2006.
Dr. Krause will give a presentation on conceptualized approaches and considerations for critical graphical analysis of clinical data, along with industry drug development professionals and technology experts, as part of an event entitled, “Transforming Data into a Graphical Output of Higher Value - Clinical Data Review & Reporting, Text & Data Mining, and Knowledge Management.” The session will include case studies and applied examples in clinical drug development, and will also offer a forum for interdisciplinary discussion of quantitative methods and tools in the drug development process. Additional information can be found at: www.insightful.com/switzerland/us/news_events/basel06/default.asp.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company’s goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight’s approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com .
Registered Trademarks and Trademarks
Pharsight(R) is a registered trademark of Pharsight Corporation. All other brand and product names are trademarks or registered trademarks of their respective holders.
Pharsight Corporation
CONTACT: investors, Douglas Sherk, or Jennifer Beugelmans,+1-415-896-6820, or media, Steve DiMattia of EVC Group, +1-646-277-8706,all of EVC Group, for Pharsight Corporation
Web site: http://www.pharsight.com/
